the ARDs have an exercise date of 2028, which seem a long time away. is MSB just covering themselve incase pending approvals don't work out or there is a chance of extend extra trials needed.
We pending partnerships with Nov, why the need for extra cash?
the recent video Si seem to suggest things like this are coming... but? not sure i can see a timeline to approvals etc ... is it just a need for additional cash for an inspected increase in production of cells, an exculation in anticipation for approvals. ?
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility, page-32
-
- There are more pages in this discussion • 420 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |